Lung collagens perpetuate pulmonary fibrosis via CD204 and M2 macrophage activation.

Idiopathic pulmonary fibrosis is characterized by abundant collagen production and accumulation of alternatively activated macrophages (M2) in the lower respiratory tract. Mechanisms as to how alveolar macrophages are activated by collagen breakdown products are unknown. Alveolar macrophages were ob...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mirjam Stahl, Jonas Schupp, Benedikt Jäger, Michael Schmid, Gernot Zissel, Joachim Müller-Quernheim, Antje Prasse
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
R
Q
Acceso en línea:https://doaj.org/article/3d3a7362be2d4a44a0c34060639c3e6c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3d3a7362be2d4a44a0c34060639c3e6c
record_format dspace
spelling oai:doaj.org-article:3d3a7362be2d4a44a0c34060639c3e6c2021-11-18T08:45:22ZLung collagens perpetuate pulmonary fibrosis via CD204 and M2 macrophage activation.1932-620310.1371/journal.pone.0081382https://doaj.org/article/3d3a7362be2d4a44a0c34060639c3e6c2013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24278429/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203Idiopathic pulmonary fibrosis is characterized by abundant collagen production and accumulation of alternatively activated macrophages (M2) in the lower respiratory tract. Mechanisms as to how alveolar macrophages are activated by collagen breakdown products are unknown. Alveolar macrophages were obtained by bronchoalveolar lavage from 30 patients with idiopathic pulmonary fibrosis (IPF) and 37 healthy donors (HD). Alveolar macrophages were cultured in the presence of collagen type I, III, IV and V monomers w/wo a neutralizing antibody against scavenger receptor I class A (CD204). Culture supernatants were assayed for the M2 markers CCL18, CCL2, and interleukin-1 receptor antagonist (IL-1ra) by ELISA. Furthermore, expression of phospho-Akt was measured using ELISA and expression of CD204 by RT-PCR and flow cytometry. Stimulation with collagen type I and III monomers significantly up-regulated CCL18, IL-1ra production of alveolar macrophages. Furthermore, expression of CCL2 and CD204 were up-regulated by collagen type I exposure. In addition, collagen type I stimulation increased pospho-Akt expression. Collagen type I effects were abrogated by neutralizing antiCD204 and a non-selective Phosphatidylinositide 3-kinase inhibitor (LY294002). Spontaneous CD204 expression of alveolar macrophages was significantly increased in patients with IPF. In conclusion, our findings demonstrate that monomeric collagen type I via CD204 induces phospho-Akt expression shifting alveolar macrophages to the profibrotic M2 type. Innate immune responses induced by collagen monomers might perpetuate pulmonary fibrosis.Mirjam StahlJonas SchuppBenedikt JägerMichael SchmidGernot ZisselJoachim Müller-QuernheimAntje PrassePublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 11, p e81382 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Mirjam Stahl
Jonas Schupp
Benedikt Jäger
Michael Schmid
Gernot Zissel
Joachim Müller-Quernheim
Antje Prasse
Lung collagens perpetuate pulmonary fibrosis via CD204 and M2 macrophage activation.
description Idiopathic pulmonary fibrosis is characterized by abundant collagen production and accumulation of alternatively activated macrophages (M2) in the lower respiratory tract. Mechanisms as to how alveolar macrophages are activated by collagen breakdown products are unknown. Alveolar macrophages were obtained by bronchoalveolar lavage from 30 patients with idiopathic pulmonary fibrosis (IPF) and 37 healthy donors (HD). Alveolar macrophages were cultured in the presence of collagen type I, III, IV and V monomers w/wo a neutralizing antibody against scavenger receptor I class A (CD204). Culture supernatants were assayed for the M2 markers CCL18, CCL2, and interleukin-1 receptor antagonist (IL-1ra) by ELISA. Furthermore, expression of phospho-Akt was measured using ELISA and expression of CD204 by RT-PCR and flow cytometry. Stimulation with collagen type I and III monomers significantly up-regulated CCL18, IL-1ra production of alveolar macrophages. Furthermore, expression of CCL2 and CD204 were up-regulated by collagen type I exposure. In addition, collagen type I stimulation increased pospho-Akt expression. Collagen type I effects were abrogated by neutralizing antiCD204 and a non-selective Phosphatidylinositide 3-kinase inhibitor (LY294002). Spontaneous CD204 expression of alveolar macrophages was significantly increased in patients with IPF. In conclusion, our findings demonstrate that monomeric collagen type I via CD204 induces phospho-Akt expression shifting alveolar macrophages to the profibrotic M2 type. Innate immune responses induced by collagen monomers might perpetuate pulmonary fibrosis.
format article
author Mirjam Stahl
Jonas Schupp
Benedikt Jäger
Michael Schmid
Gernot Zissel
Joachim Müller-Quernheim
Antje Prasse
author_facet Mirjam Stahl
Jonas Schupp
Benedikt Jäger
Michael Schmid
Gernot Zissel
Joachim Müller-Quernheim
Antje Prasse
author_sort Mirjam Stahl
title Lung collagens perpetuate pulmonary fibrosis via CD204 and M2 macrophage activation.
title_short Lung collagens perpetuate pulmonary fibrosis via CD204 and M2 macrophage activation.
title_full Lung collagens perpetuate pulmonary fibrosis via CD204 and M2 macrophage activation.
title_fullStr Lung collagens perpetuate pulmonary fibrosis via CD204 and M2 macrophage activation.
title_full_unstemmed Lung collagens perpetuate pulmonary fibrosis via CD204 and M2 macrophage activation.
title_sort lung collagens perpetuate pulmonary fibrosis via cd204 and m2 macrophage activation.
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/3d3a7362be2d4a44a0c34060639c3e6c
work_keys_str_mv AT mirjamstahl lungcollagensperpetuatepulmonaryfibrosisviacd204andm2macrophageactivation
AT jonasschupp lungcollagensperpetuatepulmonaryfibrosisviacd204andm2macrophageactivation
AT benediktjager lungcollagensperpetuatepulmonaryfibrosisviacd204andm2macrophageactivation
AT michaelschmid lungcollagensperpetuatepulmonaryfibrosisviacd204andm2macrophageactivation
AT gernotzissel lungcollagensperpetuatepulmonaryfibrosisviacd204andm2macrophageactivation
AT joachimmullerquernheim lungcollagensperpetuatepulmonaryfibrosisviacd204andm2macrophageactivation
AT antjeprasse lungcollagensperpetuatepulmonaryfibrosisviacd204andm2macrophageactivation
_version_ 1718421316379344896